Adjuvax LLC

Startup

Vaccines provide immeasurable benefits to public health. Modern vaccines contain vital components known as adjuvants, which enhance their ability to elicit and modulate a strong and durable immune response. Despite the increasingly important role of adjuvants, only three structurally defined organic adjuvants are currently approved by the FDA and available for use in human vaccines. While each of these clinical adjuvants offers valuable benefits, they also have inherent limitations. This highlights the pressing need for potent new adjuvants discovered by and being developed at Adjuvax.

At Adjuvax, we are dedicated to developing potent and cost-effective adjuvant products. Our innovative technology in adjuvant discovery paves the way for a significant expansion of the adjuvant toolbox by introducing structurally defined and highly accessible saponin adjuvants with diverse activity profiles tailored to various vaccine applications. Our mission is to develop new and unique vaccine adjuvants for the growing number of effective vaccine therapies that benefit global health.

website